Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation

Leukemia. 2005 Apr;19(4):500-3. doi: 10.1038/sj.leu.2403660.

Authors

M Mohty¹, C Faucher, D Blaise

Affiliation

¹ Unité de Transplantation et de Thérapie Cellulaire (UTTC), Département d'Hématologie, Institut Paoli-Calmettes, Marseille, France. mohtym@marseille.fnclcc.fr

PMID: 15674410
DOI: 10.1038/sj.leu.2403660

No abstract available

Publication types

Address
Research Support, Non-U.S. Gov't

MeSH terms

Graft vs Host Disease / epidemiology*
Graft vs Host Disease / physiopathology
Granulocyte Colony-Stimulating Factor / adverse effects*
Humans
Incidence
Leukemia / drug therapy*
Risk Factors
Stem Cell Transplantation*
Transplantation, Homologous

Substances

Granulocyte Colony-Stimulating Factor